Trials / Recruiting
RecruitingNCT05014971
Telehealth in Lewy Body Dementia
Multi-Stakeholder Engagement for Interdisciplinary Telehealth in Lewy Body Dementia
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 106 (estimated)
- Sponsor
- University of Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
Lewy body dementia (LBD) is the 2nd most common neurodegenerative dementia in the US. Optimal care requires an interdisciplinary approach, however often faced barriers include rural residence, limited access to specialists, travel distance, limited awareness of resources, and physical, cognitive, and behavioral impairments making travel to appointments challenging. Delivering interdisciplinary care remotely using video technology has the potential to improve access to care for patients with LBD.
Detailed description
The purpose of this study is to convert an in-person patient-centric interdisciplinary care model to a virtual platform using stakeholder engagement from individuals with LBD, their caregivers and healthcare providers. Subsequently researchers will conduct a prospective, randomized, controlled pilot study implementing the virtual stakeholder developed interdisciplinary care model (tele-neurohub) for 6 month and assess the implementation outcomes of feasibility, acceptability, and appropriateness of the tele-neurohub model. The research goal is to establish and iteratively improve a virtual interdisciplinary model of care allowing patients with LBD and their caregivers to access sub-specialty care from their home.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Tele-neurohub | Interdisciplinary care delivered using telemedicine (zoom) technology which includes neurologist, physical, occupational and speech therapy, social worker and dietician. |
Timeline
- Start date
- 2022-02-28
- Primary completion
- 2026-05-31
- Completion
- 2026-05-31
- First posted
- 2021-08-20
- Last updated
- 2025-06-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05014971. Inclusion in this directory is not an endorsement.